Yellow fever
Therapeutic area
Infectious Disease
Rare disease
Yes
- Definition
- Yellow fever (YF), caused by YF virus, is a zoonotic disease characterized by fever and constitutional symptoms, with the potential to progress to severe and fatal viral hemorrhagic fever with shock and multi-organ system failure.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- Yes
- Listing at source
- Listed
- Condition name
- Yellow fever
- Therapeutic area
- Infectious Disease
- yellow fever
- YF
- Yellow Jack
- Yellow fever Virus infection
- Yellow fever virus caused disease or disorder
- Yellow fever virus disease or disorder
- Yellow fever virus infectious disease
- bronze John
- sylvatic yellow fever
- Disease mechanisms
- Acquired
- All therapeutic areas
- Infectious Disease
- Severity
- Severe
- MONDO ID
- MONDO:0020502
- Parent condition
- MONDO:0005763
Related records
Broader conditions (10)
- Arbovirus fever
- Disease
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Flaviviridae infectious disease
- Human disease
- Infectious disease
- Primary viral infectious disease
- Vector-borne disease
- Viral infectious disease
Trials (44)
- A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults
- A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population
- A Pilot Study to Finetune Skin Processing Procedures in Recent Vaccinees, Prior to GeKoSkimm Study Initiation (GeKoSkimm-pilot)
- A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL
- A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants
- A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19
- A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults
- A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers
- An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity
- Baseline Assessment of Skin Resident Memory T Cells in Healthy Unvaccinated Participants
- Booster Vaccine for Yellow Fever
- Characterization of T Cell Responses Following Yellow Fever Virus Vaccination in Healthy Adults
- Complementary Study of the Duration of Post-vaccination Against Yellow Fever Immunity in Children
- Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults
- Evaluation of an Infant Immunization Encouragement Program in Nigeria
- Human Immune Responses to Yellow Fever Vaccination
- Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine
- Immunity After Two Doses of Yellow Fever Vaccine
- Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination
- Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE)